Gerodermia osteodysplastica is an autosomal recessive disorder characterized by wrinkly skin and osteoporosis. Here we demonstrate that gerodermia osteodysplastica is caused by lossof-function mutations in SCYL1BP1, which is highly expressed in skin and osteoblasts. The protein localizes to the Golgi apparatus and interacts with Rab6, identifying SCYL1BP1 as a golgin. These results associate abnormalities of the secretory pathway with age-related changes in connective tissues.
Lax and wrinkly skin as well as a reduction of bone mass are characteristic changes associated with human aging. Although the heritability of peak bone mass has been estimated to range between 60 and 70%, only a few genetic determinants have been identified so far. Skin wrinkling is a feature of several uncommon monogenic disorders that have so far been mainly assigned to mutations in extracellular matrix components (Supplementary Note online). In this study we investigated the molecular cause of gerodermia osteodysplastica (also known as geroderma osteodysplasticum, MIM231070), a rare autosomal recessive disorder characterized by lax, wrinkled skin, joint laxity and a typical face with a prematurely aged appearance. Skeletal signs include severe osteoporosis leading to frequent fractures, malar and mandibular hypoplasia and a variable degree of growth retardation 1, 2 . According to the current definition, gerodermia osteodysplastica can be regarded as a segmental progeroid disorder involving bone and skin 3 .
Our study involved individuals from 13 families all showing the typical gerodermia osteodysplastica phenotype (Fig. 1a , Supplementary Methods and Supplementary Fig. 1 online) . The study has been approved by the local institutional review board and followed the Declaration of Helsinki protocols. Samples were taken after obtaining written informed consent. Bone mineral density was significantly reduced in all affected individuals, frequently resulting in fractures of long bones or vertebrae ( Supplementary Fig. 1 ). We carried out linkage analysis initially in four Mennonite pedigrees with a total of 12 affected individuals from Germany, Mexico and Canada without known relationship to one another (Supplementary Methods). The Anabaptist community of the Mennonites was founded in the sixteenth century in Friesland in the north of The Netherlands, and after periods of prosecution, a large part of the community migrated to Northern and Middle America. Many of them kept a common, specific language, an ancient German dialect also known as Mennonite Low German.
A genome-wide scan identified a homozygous region on chromosome 1q24 with a combined multipoint lod score of 12.0 (Supplementary Fig. 2 online) . The shared homozygous haplotype in all affected persons from the Mennonite pedigrees was consistent with a founder effect and defined a candidate region between markers D1S1569 and D1S218 (Fig. 1b) , which is 5.1 cM in length, corresponding to 5.7 Mb containing 102 genes. In a systematic sequencing approach we detected a homozygous nonsense mutation, 367G4T (E123X, NM_152281) in the gene SCYL1BP1 (FLJ11752, NTKLBP1) in all affected individuals from all four Mennonite families ( States, we found eight other mutations, including five nonsense mutations, two frameshift mutations, one splice-site mutation and one mutation affecting the deduced methionine start codon (Fig. 1c and Table 1 ). Obligatory carriers were all heterozygous for the respective mutation, and the mutations were not found on 100 chromosomes from ancestry-matched control persons. A reading frame of 394 codons has been predicted for SCYL1BP1 (NM_152281). However, the sequence of SCYL1BP1 is highly conserved among species, and a comparison with orthologous sequences makes a later translation start, resulting in a 369-codon reading frame, much more likely. This translational start is further corroborated by the prediction of translation using the algorithm NetStart 4 .
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Staining with markers for cellular compartments showed a clear localization of SCYL1BP1 to the Golgi apparatus ( Fig. 1e and Supplementary Methods). No significant alterations in Golgi morphology or in the distribution of different Golgi marker proteins were detected in fibroblasts of affected individuals ( Supplementary  Fig. 3 online) . Scyl1bp1 showed high expression in osteoblasts and in the skin ( Supplementary Fig. 4 online), which correlates with the main sites of disease manifestation. Protein expression was shown to increase during osteoblast differentiation. Expression was also present in osteoclasts, albeit at lower levels.
As SCYL1BP1 is a soluble protein with coiled-coil domains known to mediate protein-protein interaction, we sought its binding partners in a library of mammalian small G proteins of the Rab, ARF and Arl families that are known to be important determinants of intracellular membrane traffic 5 using a yeast two-hybrid interaction screen. We identified a specific interaction of SCYL1BP1 with Rab6 (Fig. 1f) . Pulldown experiments confirmed this interaction. The interaction was additionally shown to be dependent on the activation state of Rab6, thus further corroborating its specificity (Fig. 1g) . In contrast, an interaction with Rab1 was not detected, confirming the specificity of the yeast two-hybrid screening ( Supplementary Fig. 5 online) . Golgi localization, the presence of coiled-coil domains and the interaction with a Rab protein are the hallmarks of the golgin protein family 6 . Therefore, SCYL1BP1 can be classified as a golgin. To our knowledge, this is the first example of a golgin causing a hereditary human disorder.
Mouse Scyl1bp1 was identified initially as a binding partner of the N-terminal kinase-like protein (Scyl1) in a yeast two-hybrid analysis 7 . Scyl1 was shown to be mutated in the mdf mouse mutant that shows spinocerebellar neurodegeneration 8 . Human SCYL1 was found to bind to adaptor proteins of clathrin-coated vesicles 9 , and a recent search for binding partners of Scyl1 by mass spectrometry identified an interaction with components of coatomer complex I (COPI) coats 10 . This observation fits very well with our finding that SCYL1BP1 is associated with the Golgi apparatus and involved in the secretory pathway.
The three Rab6 isoforms are central components of cellular membrane trafficking, mainly residing in the trans-Golgi network 5 .
One important function of Rab6 is the recruitment of motor proteins that promote vesicle movement. Rab6 is known to be involved in the retrograde transport from endosomes to the Golgi apparatus and has a crucial role in the secretory pathway from the Golgi to the plasma membrane 11, 12 . Also, a functional interaction of Rab6 with the conserved oligomeric Golgi complex (COG) has been demonstrated recently 13 . This is of note as individuals with mutations affecting COG7, a subunit of this complex, show glycosylation defects and wrinkled skin 14 . Impaired glycosylation, wrinkly skin and bone defects are also features observed in autosomal recessive cutis laxa type 2 (ARCL2; MIM219200). ARCL2 was recently shown to be due to mutations in the vacuolar-type H + -ATPase subunit gene ATP6V0A2 (ref. 15) . Given the phenotypic similarities between gerodermia osteodysplastica and ARCL2, we analyzed the glycosylation pattern of serum transferrin from individuals with gerodermia osteodysplastica but did not detect any glycosylation abnormalities 2 .
Our results show that two common aging phenomena, skin wrinkling and osteoporosis, can be associated with mutations affecting a newly identified golgin, SCYL1BP1. Future studies are needed to investigate the pathophysiological similarities between gerodermia osteodysplastica and overlapping disorders to identify a putative common mechanism regulating connective tissue homeostasis during aging.
Note: Supplementary information is available on the Nature Genetics website.
